share_log

迈威生物自愿披露关于9MW2821用于尿路上皮癌适应症纳入突破性治疗品种的公告

Meiwei Biopharmaceutical voluntarily disclosed the announcement on the inclusion of 9MW2821 for the indication of urothelial carcinoma into breakthrough therapy drugs.

SZSI ·  Aug 11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more